platinum has been researched along with mitomycin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breau, JL; Clavier, J; Gres, JJ; Israël, L; Lerebours-Pigeonnière, G; Morère, JF; Nouvet, G; Raut, Y; Zabbe, C | 1 |
| Bradner, WT; Iyengar, BS; Remers, WA; Takahashi, T | 1 |
| Jeffrey, AM | 1 |
| Bernard, JP; Fournel, P; Jorda, M; Laennec, E; Piperno, D; Rebattu, P; Souquet, PJ; Trillet, V | 1 |
| Arimori, M; Furukawa, T; Ishibiki, K; Isobe, Y; Kase, S; Kubota, T; Kuo, TH; Saikawa, Y; Tanino, H; Watanabe, M | 1 |
| Almadrones, L; Barakat, R; Curtin, J; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S | 1 |
| Furukawa, T; Ishibiki, K; Kase, S; Kitajima, M; Kubota, T; Kuo, TH; Saikawa, Y; Tanino, H | 1 |
| Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Fujitoh, A; Isaka, K; Ito, H; Nishi, H; Sagawa, Y; Yudate, T | 1 |
| Ando, T; Fujinami, H; Horikawa, N; Hosokawa, A; Kajiura, S; Kobayashi, T; Mihara, H; Minemura, M; Nishikawa, J; Note, M; Ogawa, K; Sugiyama, T; Terada, M; Ueda, A; Yabushita, K; Yoshita, H | 1 |
1 review(s) available for platinum and mitomycin
| Article | Year |
|---|---|
DNA modification by chemical carcinogens.
Topics: 4-Nitroquinoline-1-oxide; Aflatoxins; Alkylating Agents; Animals; Benz(a)Anthracenes; Benzo(a)pyrene; Benzodiazepinones; Biotransformation; Carcinogens; Chemical Phenomena; Chemistry; Chrysenes; DNA; DNA Replication; Epoxy Compounds; Fluorenes; Furocoumarins; Humans; Immunologic Techniques; Isotope Labeling; Mitomycin; Mitomycins; Naphthalenes; Oxides; Platinum; Pyrenes; Safrole; Spectrometry, Fluorescence | 1985 |
2 trial(s) available for platinum and mitomycin
| Article | Year |
|---|---|
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Platinum; Vindesine | 1993 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
7 other study(ies) available for platinum and mitomycin
| Article | Year |
|---|---|
Preliminary results of preoperative chemotherapy with a combination of platinum-bleomycin administered in 5-day cycles in carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Platinum; Postoperative Complications; Vindesine | 1986 |
Metal complexes of mitomycins.
Topics: Animals; Chemical Phenomena; Chemistry; Chlorides; Copper; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Mitomycin; Mitomycins; Platinum; Platinum Compounds; Zinc; Zinc Compounds | 1986 |
Synergistic antitumor activity of combination chemotherapy with mitomycin C and cisplatin against human gastric cancer xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Platinum; Stomach Neoplasms; Time Factors; Transplantation, Heterologous | 1994 |
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Female; Fluorouracil; Humans; Infusions, Intravenous; Middle Aged; Mitomycin; Ovarian Neoplasms; Platinum; Salvage Therapy | 1993 |
Synergistic antitumor activity of mitomycin C and cisplatin against gastric cancer cells in vitro.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Humans; Mitomycin; Platinum; Stomach Neoplasms; Tumor Cells, Cultured | 1993 |
Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Mitomycin; Neoplasm Invasiveness; Platinum | 2011 |
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Staging; Platinum; Prognosis; Salvage Therapy; Stomach Neoplasms; Survival Rate | 2013 |